Wegovy 4mg GLP-1 Pill, 30 Tablets, for Weight Loss Support

Wegovy 4mg Tablets are a prescription-only, once-daily oral GLP-1 receptor agonist treatment containing semaglutide, developed by Novo Nordisk to support adults living with obesity or overweight with weight-related health conditions. As part of a comprehensive medical weight management approach, Wegovy® Pill is designed to promote clinically proven and sustainable weight loss when combined with a balanced diet and increased physical activity. Wegovy® Pill works with the body's natural mechanisms by reducing appetite, increasing feelings of fullness, and helping individuals eat less over time. Built on semaglutide, a molecule supported by more than eight years of clinical studies and real-world experience in diabetes and weight management, the treatment offers an established safety profile and extensive clinical evidence.

The 4mg strength is used during the dose-escalation phase following the initial 1.5mg starting dose. Its once-daily tablet format offers a convenient alternative to injections for individuals with an oral preference, fitting easily into daily routines. Taken in the morning on an empty stomach with a sip of water and followed by a 30-minute wait before eating or drinking, Wegovy® Pill is designed to support long-term treatment adherence and healthy lifestyle habits.

Benefits

• Contains semaglutide, a GLP-1 receptor agonist with over 8 years of clinical experience.
• Once-daily tablet format provides an alternative to injectable GLP-1 therapies.
• Works with the body's natural mechanisms to reduce appetite and enhance feelings of fullness.
• Designed to support clinically proven, gradual, and sustainable weight management.
• Can be incorporated into a simple morning routine.
• Intended for long-term use as part of a medical weight management program.
• No injections required, making administration convenient for those with an oral preference.
• Clinical studies reported average weight reduction of approximately 17%, with some participants achieving 20% or greater weight loss.
• Established safety profile consistent with the GLP-1 receptor agonist class.

Suggested Usage : Wegovy 4mg Tablets should only be used under the supervision of a healthcare professional. During the dose-escalation phase, take one tablet once daily in the morning on an empty stomach with up to half a cup of water. Wait at least 30 minutes before eating, drinking, or taking other oral medications. Continue each prescribed dose level for approximately 30 days before progressing according to your healthcare provider's instructions.

Suitable For

• Adults aged 18 years and above.
• Individuals living with obesity.
• Adults who are overweight and have weight-related health conditions.
• People who prefer oral tablets over injectable treatments.
• Individuals seeking a physician-supervised weight management approach.
• Those committed to combining treatment with balanced nutrition and increased physical activity.
• Not suitable for individuals with hypersensitivity to semaglutide or any formulation components.

Product Specifications